Evolving Approaches to Patients with Advanced Differentiated Thyroid Cancer

Por Haugen, Bryan R., Sherman, Steven I.
Publicado em 2013

Applying New Clinicopathologic Characteristics to Prognostication in Advanced Thyroid Carcinoma

Por Cabanillas, Maria E., Sherman, Steven I.
Publicado em 2012

A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer

Por Cabanillas, Maria E., Brose, Marcia S., Holland, Jaymes, Ferguson, Kimberly C., Sherman, Steven I.
Publicado em 2014

Long-term Eradication of Locally Recurrent Invasive Follicular Thyroid Carcinoma after Taxane-based Concomitant Chemoradiotherapy

Por Tulloch-Reid, Marshall, Skarulis, Monica C., Sherman, Steven I., Sarlis, Nicholas J., Santarpia, Libero
Publicado em 2009

Mosaicism in von Hippel-Lindau disease: an event important to recognize

Por Santarpia, Libero, Sarlis, Nicholas J, Santarpia, Mariacarmela, Sherman, Steven I, Trimarchi, Francesco, Benvenga, Salvatore
Publicado no J Cell Mol Med (2007)

In Papillary Thyroid Cancer, Preoperative Central Neck Ultrasound Detects Only Macroscopic Surgical Disease, But Negative Findings Predict Excellent Long-Term Regional Control and...

Por Moreno, Mauricio A., Edeiken-Monroe, Beth S., Siegel, Eric R., Sherman, Steven I., Clayman, Gary L.
Publicado em 2012

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

Por Drucker, Daniel J., Sherman, Steven I., Gorelick, Fred S., Bergenstal, Richard M., Sherwin, Robert S., Buse, John B.
Publicado em 2010

Long-Term Outcome of Comprehensive Central Compartment Dissection in Patients with Recurrent/Persistent Papillary Thyroid Carcinoma

Por Clayman, Gary L., Agarwal, Garima, Edeiken, Beth S., Waguespack, Steven G., Roberts, Dianna B., Sherman, Steven I.
Publicado em 2011

INHIBITION OF PITUITARY TUMOR-TRANSFORMING GENE-1 IN THYROID CANCER CELLS BY DRUGS THAT DECREASE SPECIFICITY PROTEINS

Por Chintharlapalli, Sudhakar, Papineni, Sabitha, Lee, Syng-Ook, Lei, Ping, Jin, Un Ho, Sherman, Steven I., Santarpia, Libero, Safe, Stephen
Publicado em 2011

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced o...

Por Brose, Marcia S, Nutting, Christopher M, Sherman, Steven I, Shong, Young Kee, Smit, Johannes WA, Reike, Gerhard, Chung, John, Kalmus, Joachim, Kappeler, Christian, Schlumberger, Martin
Publicado em 2011

Clinical trial characteristics and barriers to participant accrual: The MD Anderson Cancer Center experience over 30 years, a historical foundation for trial improvement

Por Tang, Chad, Sherman, Steven I., Price, Mellanie, Weng, Jun, Davis, Suzanne E., Hong, David S., Yao, James C., Buzdar, Aman, Wilding, George, Lee, J. Jack
Publicado no Clin Cancer Res (2017)

Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer–Related Diarrhea and Its Effects on Quality of Life: A Pilot Study

Por Dadu, Ramona, Hu, Mimi I., Cleeland, Charles, Busaidy, Naifa L., Habra, Mouhammed, Waguespack, Steven G., Sherman, Steven I., Ying, Anita, Fox, Patricia, Cabanillas, Maria E.
Publicado no Thyroid (2015)

Phase I Clinical Trials in 56 Patients with Thyroid Cancer: The M. D. Anderson Cancer Center Experience

Por Tsimberidou, Apostolia Maria, Vaklavas, Christos, Wen, Sijin, Hong, David, Wheler, Jennifer, Ng, Chaan, Naing, Aung, Tse, Susan, Busaidy, Naifa, Markman, Maurie, Sherman, Steven I., Kurzrock, Razelle
Publicado em 2009

Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring BRAF(V600E) Mutation

Por Kim, Kevin B., Cabanillas, Maria E., Lazar, Alexander J., Williams, Michelle D., Sanders, Deborah L., Ilagan, Joseph L., Nolop, Keith, Lee, Richard J., Sherman, Steven I.
Publicado em 2013

Post-Operative External Beam Radiotherapy for Differentiated Thyroid Cancer—Outcomes and Morbidity with Conformal Treatment

Por Schwartz, David L., Lobo, Mark J., Ang, K. Kian, Morrison, William H., Rosenthal, David I., Ahamad, Anesa, Evans, Douglas B., Clayman, Gary, Sherman, Steven I., Garden, Adam S.
Publicado em 2008

Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes

Por Haddad, Robert I., Schlumberger, Martin, Wirth, Lori J., Sherman, Eric J., Shah, Manisha H., Robinson, Bruce, Dutcus, Corina E., Teng, Angela, Gianoukakis, Andrew G., Sherman, Steven I.
Publicado no Endocrine (2017)

Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer

Por Dadu, Ramona, Waguespack, Steven G., Sherman, Steven I., Hu, Mimi I., Busaidy, Naifa L., Jimenez, Camilo, Habra, Mohammed A., Ying, Anita K., Bassett, Roland L., Cabanillas, Maria E.
Publicado em 2014

BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer

Por Falchook, Gerald S., Millward, Michael, Hong, David, Naing, Aung, Piha-Paul, Sarina, Waguespack, Steven G., Cabanillas, Maria E., Sherman, Steven I., Ma, Bo, Curtis, Martin, Goodman, Vicki, Kurzrock, Razelle
Publicado no Thyroid (2015)

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

Por Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J., Dutcus, Corina E., Song, James, Taylor, Matthew H., Kim, Sung-Bae, Krzyzanowska, Monika K., Capdevila, Jaume, Sherman, Steven I., Tahara, Makoto
Publicado no J Clin Endocrinol Metab (2016)

Efficacy and Tolerability of Vemurafenib in Patients with BRAF(V600E) -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience

Por Dadu, Ramona, Shah, Komal, Busaidy, Naifa L., Waguespack, Steven G., Habra, Mouhammad A., Ying, Anita K., Hu, Mimi I., Bassett, Roland, Jimenez, Camilo, Sherman, Steven I., Cabanillas, Maria E.
Publicado no J Clin Endocrinol Metab (2015)